Martin JN

Infection staging and incidence surveillance applications of high dynamic range diagnostic immuno-assay platforms
Grebe PE, Welte A, Hall J, Keating SM, Facente SN, Marson K, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD, Murphy G

Journal of Acquired Immune Deficiency Syndromes

(2017)

https://doi.org/10.1097/QAI.0000000000001537
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting “Recent”HIV Infection and Calculating Population Incidence
Keating SM, Kassanjee R, Lebedeva M, Facente SN, Macarthur JC, Grebe PE, Murphy G, Welte A, Martin JN, Little SJ, Price MA, Kallas EG, Busch MP, Pilcher CD

Journal of Acquired Immune Deficiency Syndromes

(2016)

https://doi.org/10.1097/QAI.0000000000001146
Viral load criteria and threshold optimization to improve HIV incidence assay characteristics
Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, McKinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A

AIDS

(2016)

https://doi.org/110.1097/QAD.0000000000001209
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, Murphy G

AIDS

(2014)

https://doi.org/10.1097/QAD.0000000000000429